Purpose of the company: Trading in all types of goods, in particular re-imports of pharmaceutical products, as well as trading in medical devices. MPA Pharma GmbH, together with the distribution company EMRA-MED Arzneimittel GMBH, is a supplier of re/imported and parallel-imported medicines in Germany.
Share capital: 2.500.000 DM
Adress: Otto-Hahn-Str. 11 22946 Trittau Deutschland
Local court: 23568 Lübeck
Register number: HRB142AH
The average total assets of company MPA Pharma GmbH over the last 4 years is 150.146.813,84 €.
The company MPA Pharma GmbH as of the reporting date 2023 a bank balance of approx. 21.489,24 €. That is -99,93 % less than the average bank balance in the industry of companies with this total assets.
The equity ratio of MPA Pharma GmbH is 55,80 % in the year 2023. In total, that ist 73.839.573,00 €.
The average absolute change in liquidity of the company MPA Pharma GmbH compared to the previous year amounts to -11.582,96 €. That means that the liquidity of the company has increased or decreased by this amount per year on average.
The cash flow of the company MPA Pharma GmbH amounts to -34.748,87 € in the year 2023.
The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.
The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).
All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.
Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.